|
Dr. Kelley has been Director of the University of Utah's Cell Therapy Facility since 1994, gaining international recognition in the cellular therapy field for her work there. She serves on multiple boards and committees advising on scientific policy and establishing standards and regulations for the stem cell field, including the Foundation for Accreditation of Cellular Therapy (FACT), the Cord Blood Standards Committee for the National Marrow Donor Program (NMDP), and the Committee of the National Academy of Sciences to advise congress on structure and budget for the national cord blood program. She has also established the Utah Umbilical Cord Blood Program. Dr. Kelley and her team are currently facilitating FDA approval for iniation of several Phase I clinical trials for treatment of degenerative diseases using novel stem cell therapies. She was recently awarded a Center of Excellence in Cell Therapy and Regenerative Medicine for the State of Utah. | 